Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-11-07
2006-11-07
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007210, C436S063000, C436S086000, C436S173000, C436S518000, C530S350000
Reexamination Certificate
active
07132244
ABSTRACT:
The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer, predict disease risk assessment, and develop therapeutic avenues against the disease.
REFERENCES:
patent: 5062935 (1991-11-01), Schlag et al.
patent: 5766848 (1998-06-01), Borden
patent: 6020208 (2000-02-01), Hutchens et al.
patent: 6225047 (2001-05-01), Hutchens et al.
patent: 2002/0164668 (2002-11-01), Durham et al.
patent: WO 90/14148 (1990-11-01), None
patent: WO 93/24834 (1993-12-01), None
patent: WO 98/07036 (1998-02-01), None
patent: WO 01/63280 (2001-08-01), None
patent: WO 01/75454 (2001-10-01), None
Zhang et al. Neurobiology of Aging, vol. 26, p. 207 (2005).
Takahashi et al., “Rapid and Sensitive Immunoassay for the Measurement of Serum S100β Using Isoform-specific Monoclonal Antibody”, Clinical Chemistry 45, No. 8, (1999) pp. 1307-1311.
Richter et al., “Composition of the peptide fraction in human blood plasma: database of circulating human peptides”, Journal of Chromatography B; 726 (1999) pp. 25-35.
Bristow, et al., “Specific Activity of α1Proteinase Inhibitor and α2Macroglobulin in Human Serum: Application to Insulin-Dependent Diabetes Mellitus”, Clinical Immunology & Immunopathology (1998) vol. 89, No. 3, pp. 247-259.
Trefz, et al., “Establishment of an Enzyme-Linked Immuno-Sorbent Assay for Urinary Trypsin Inhibitor by Using a Monoclonal Antibody”, Journal of Immunoassay (1991), vol. 12, No. 3, pp. 347-369.
M. Hua et al, “Transgenic Mice Overexpressing -aminobutyric Acid Transporter Subtype I Develop Obesity”, Cell Research, 10(4):303-310 (Dec., 2000).
Jackowski George
Marshall John
Cheu Jacob
Le Long V.
McHale & Slavin P.A.
Syn X Pharma, Inc.
LandOfFree
Betaine/GABA transport protein biopolymer marker indicative... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Betaine/GABA transport protein biopolymer marker indicative..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Betaine/GABA transport protein biopolymer marker indicative... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3679155